GlassScriptPhysician profile
Katie Fain
NPI 1720556509
$2,946.66
in general payments reported to CMS, 2019-2025
20 companies · $16.58 in 2025
The $16.58 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $267 · 2022: $1,720 · 2023: $753 · 2024: $190 · 2025: $16.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.39 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,346.05 | 2021-2024 | |
| Abbvie INC. | $253.78 | 2021-2023 | |
| Astellas Pharma US INC | $224.59 | 2023-2024 | Veozah |
| Scynexis, INC. | $178.24 | 2022 | |
| Myriad Women'S Health, INC. | $121.16 | 2023 | Myrisk |
| Aspira Women'S Health INC | $119.01 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $115.30 | 2021-2023 | |
| Hologic Sales and Service, LLC | $102.24 | 2022-2024 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Novo Nordisk INC | $82.37 | 2022 | |
| Therapeuticsmd, INC. | $81.55 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $75.91 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $69.70 | 2021-2022 | |
| Exact Sciences Corporation | $57.01 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.50 | 2023 | |
| Axonics, INC. | $19.50 | 2023 | Axonics |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $18.97 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.58 | 2025 | Lynparza |
| Acessa Health INC. | $16.36 | 2021 | |
| Agile Therapeutics, INC. | $14.75 | 2022 | |
| Exeltis, USA INC. | $14.09 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Fain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.